Christophe Fromont

Christophe Fromont is a distinguished Principal Scientist specializing in Medicinal Chemistry at KalVista Pharmaceuticals, Inc., since July 2021. Prior experience includes a Senior Scientist role at Charnwood Molecular, where organic and medicinal chemistry support was provided to clients from December 2019 to July 2021. From December 2008 to April 2019, Christophe served as a Research Fellow at the University of Nottingham, leading a team on a Wellcome Trust-funded project focused on selective Beta1 blockers. Earlier in the career, Christophe worked as a Medicinal Chemist at Vernalis from October 1999 to March 2008, contributing to the design of low micro molar hit ligands. Academic qualifications include a PhD in Organic Chemistry from Université de Caen Normandie (1994-1997) and a Postdoctoral fellowship in Solid Phase Chemistry from the University of Southampton (1998-1999).